Published in Am J Obstet Gynecol on April 21, 2006
Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression. Proc Natl Acad Sci U S A (2011) 2.12
Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands. J Virol (2007) 1.24
Lymphocytic choriomeningitis infection of the central nervous system. Front Biosci (2008) 1.21
High diversity and ancient common ancestry of lymphocytic choriomeningitis virus. Emerg Infect Dis (2010) 1.14
Cellular entry of lymphocytic choriomeningitis virus. J Virol (2007) 1.12
Ribavirin can be mutagenic for arenaviruses. J Virol (2011) 1.03
Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers. Virology (2007) 1.02
Lymphocytic choriomeningitis virus meningitis, New York, NY, USA, 2009. Emerg Infect Dis (2010) 1.01
Viral causes of hearing loss: a review for hearing health professionals. Trends Hear (2014) 0.99
A technological update of molecular diagnostics for infectious diseases. Infect Disord Drug Targets (2008) 0.95
Receptor use by the Whitewater Arroyo virus glycoprotein. Virology (2007) 0.93
Emerging and zoonotic infections in women. Infect Dis Clin North Am (2008) 0.89
Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV. Nat Struct Mol Biol (2016) 0.87
The nucleoprotein of lymphocytic choriomeningitis virus facilitates spread of persistent infection through stabilization of the keratin network. J Virol (2009) 0.84
Host cell factors as antiviral targets in arenavirus infection. Viruses (2012) 0.81
Arenaviruses and lethal mutagenesis. Prospects for new ribavirin-based interventions. Viruses (2012) 0.79
Hypoxia induces the gene expression and extracellular transmission of persistent lymphocytic choriomeningitis virus. J Virol (2011) 0.78
A pilot study using residual newborn dried blood spots to assess the potential role of cytomegalovirus and Toxoplasma gondii in the etiology of congenital hydrocephalus. Birth Defects Res A Clin Mol Teratol (2013) 0.76
H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet (2009) 12.32
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med (2010) 8.51
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA (2010) 5.94
Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics (2005) 4.91
Comparison of hypothermia and normothermia after severe traumatic brain injury in children (Cool Kids): a phase 3, randomised controlled trial. Lancet Neurol (2013) 4.20
Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol (2011) 4.14
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med (2007) 3.79
Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis (2007) 3.47
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet (2002) 3.35
The contribution of preterm birth to infant mortality rates in the United States. Pediatrics (2006) 3.01
A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics (2003) 2.88
Emerging infections and pregnancy. Emerg Infect Dis (2006) 2.75
Integrating family planning and prevention of mother-to-child HIV transmission in resource-limited settings. Lancet (2005) 2.73
Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial. Lancet (2012) 2.69
Baseline serum concentrations of zinc, selenium, and prolactin in critically ill children. Pediatr Crit Care Med (2013) 2.66
Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics (2006) 2.53
Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med (2007) 2.43
Maternal obesity and risk for birth defects. Pediatrics (2003) 2.33
Effectiveness of malaria control during changing climate conditions in Eritrea, 1998-2003. Trop Med Int Health (2008) 2.24
An outbreak of community-acquired foodborne illness caused by methicillin-resistant Staphylococcus aureus. Emerg Infect Dis (2002) 2.15
What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention. Obstet Gynecol (2014) 2.04
A multicenter prospective study of 3,110 consecutive cases of elective epinephrine use in the fingers and hand: the Dalhousie Project clinical phase. J Hand Surg Am (2005) 1.96
Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care (2010) 1.94
Clinical presentation of nipah virus infection in Bangladesh. Clin Infect Dis (2008) 1.91
Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol (2006) 1.88
Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57. J Immunol (2005) 1.82
Maternal nutrient intakes and risk of orofacial clefts. Epidemiology (2006) 1.70
2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol (2011) 1.69
Association between pregnancy intention and reproductive-health related behaviors before and after pregnancy recognition, National Birth Defects Prevention Study, 1997-2002. Matern Child Health J (2009) 1.68
Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology (2007) 1.67
Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol (2011) 1.66
Prescription medication borrowing and sharing among women of reproductive age. J Womens Health (Larchmt) (2008) 1.64
A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet A (2008) 1.63
Are children born after assisted reproductive technology at increased risk for adverse health outcomes? Obstet Gynecol (2004) 1.61
Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol (2012) 1.56
Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission. Clin Infect Dis (2012) 1.56
Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.56
Malaria stratification, climate, and epidemic early warning in Eritrea. Am J Trop Med Hyg (2007) 1.56
Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A (2009) 1.55
Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions. Am J Obstet Gynecol (2007) 1.55
A call for full public disclosure and moratorium on donation after cardiac death in children. Pediatr Crit Care Med (2010) 1.54
Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep (2004) 1.52
Health concerns of women and infants in times of natural disasters: lessons learned from Hurricane Katrina. Matern Child Health J (2007) 1.48
Reconstitution of thymic function in HIV-1 patients treated with highly active antiretroviral therapy. Clin Immunol (2003) 1.45
Pillars article: generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA, 81: 3180-3184, May 1984. J Immunol (2008) 1.40
Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol (2009) 1.38
Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission. Infect Control Hosp Epidemiol (2003) 1.36
Avoiding flexor tendon repair rupture with intraoperative total active movement examination. Plast Reconstr Surg (2010) 1.35
Safety of tenofovir during pregnancy for the mother and fetus: a systematic review. Clin Infect Dis (2013) 1.35
Socioeconomic disadvantage as a social determinant of teen childbearing in the U.S. Public Health Rep (2013) 1.34
Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol (2007) 1.34
Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.29
Patterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol (2010) 1.28
F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers. J Biol Chem (2005) 1.28
Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter? Am J Obstet Gynecol (2007) 1.25
Prevention of mother-to-child transmission of HIV-1 through breast-feeding: past, present, and future. J Infect Dis (2004) 1.24
The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol (2011) 1.24
Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.21
Maternal attitudes toward DNA collection for gene-environment studies: a qualitative research study. Am J Med Genet A (2009) 1.18
A lipid-based nutrient supplement mitigates weight loss among HIV-infected women in a factorial randomized trial to prevent mother-to-child transmission during exclusive breastfeeding. Am J Clin Nutr (2012) 1.18
Priorities for future public health research in orofacial clefts. Cleft Palate Craniofac J (2007) 1.18
Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A (2009) 1.17
Maternal and fetal outcomes among women with depression. J Womens Health (Larchmt) (2010) 1.16
Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn. N Engl J Med (2006) 1.16
Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi. J Acquir Immune Defic Syndr (2010) 1.15
Microglia and inflammation: impact on developmental brain injuries. Ment Retard Dev Disabil Res Rev (2006) 1.14
Correlates of seasonal influenza vaccine coverage among pregnant women in Georgia and Rhode Island. Obstet Gynecol (2010) 1.13
Maternal periconceptional alcohol consumption and risk of orofacial clefts. Am J Epidemiol (2007) 1.13
Rates of hospital-acquired respiratory illness in Bangladeshi tertiary care hospitals: results from a low-cost pilot surveillance strategy. Clin Infect Dis (2010) 1.12
Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies. Emerg Infect Dis (2006) 1.11
The thymus during HIV disease: role in pathogenesis and in immune recovery. Curr HIV Res (2004) 1.11
Medication use during pregnancy and lactation: an urgent call for public health action. J Womens Health (Larchmt) (2005) 1.10
Zika Virus Infection Among U.S. Pregnant Travelers - August 2015-February 2016. MMWR Morb Mortal Wkly Rep (2016) 1.08
Risk mapping and early warning systems for the control of meningitis in Africa. Vaccine (2007) 1.07
Expression of pregnancy-associated plasma protein A2 during pregnancy in human and mouse. J Endocrinol (2009) 1.07
Obstetrician/gynecologists' knowledge, attitudes, and practices regarding prevention of infections in pregnancy. J Womens Health (Larchmt) (2009) 1.03
Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States. Am J Obstet Gynecol (2007) 1.03
Prevalence of self-reported infection during pregnancy among control mothers in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2009) 1.02
Population-based study of congenital diaphragmatic hernia: risk factors and survival in Metropolitan Atlanta, 1968-1999. Birth Defects Res A Clin Mol Teratol (2003) 1.02
Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study. J Clin Virol (2012) 1.02
Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry. J Infect Dis (2008) 1.01
Pregnancy and susceptibility to infectious diseases. Infect Dis Obstet Gynecol (2013) 1.01
Risk factors for non-syndromic holoprosencephaly in the National Birth Defects Prevention Study. Am J Med Genet C Semin Med Genet (2010) 1.01
Fetal constraint as a potential risk factor for craniosynostosis. Am J Med Genet A (2010) 1.00
Pregnancy and infection. N Engl J Med (2014) 0.99
Posttraumatic seizures in children with severe traumatic brain injury. Childs Nerv Syst (2012) 0.99
Health of children 3 to 17 years of age with Down syndrome in the 1997-2005 national health interview survey. Pediatrics (2009) 0.99
Current estimate of Down Syndrome population prevalence in the United States. J Pediatr (2013) 0.98
Prepregnancy obesity: a complex risk factor for selected birth defects. Birth Defects Res A Clin Mol Teratol (2010) 0.98
Seasonal influenza vaccine coverage among pregnant women: pregnancy risk assessment monitoring system. J Womens Health (Larchmt) (2011) 0.97
Common data elements for pediatric traumatic brain injury: recommendations from the biospecimens and biomarkers workgroup. J Neurotrauma (2011) 0.97
T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected women. J Acquir Immune Defic Syndr (2007) 0.97
Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy. AIDS (2015) 0.97
Maternal use of bupropion and risk for congenital heart defects. Am J Obstet Gynecol (2010) 0.96
Pregnancy termination following prenatal diagnosis of anencephaly or spina bifida: a systematic review of the literature. Birth Defects Res A Clin Mol Teratol (2012) 0.96
Risk of birth defects among children conceived with assisted reproductive technology: providing an epidemiologic context to the data. Fertil Steril (2005) 0.96
Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007. Birth Defects Res A Clin Mol Teratol (2012) 0.96
Cerebrovascular response in children following severe traumatic brain injury. Childs Nerv Syst (2011) 0.95
Examining the evidence for vascular pathogenesis of selected birth defects. Am J Med Genet A (2010) 0.95
Knowledge and attitudes of adults towards smoking in pregnancy: results from the HealthStyles© 2008 survey. Matern Child Health J (2015) 0.95